0001209191-16-147964.txt : 20161102 0001209191-16-147964.hdr.sgml : 20161102 20161102170426 ACCESSION NUMBER: 0001209191-16-147964 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20161031 FILED AS OF DATE: 20161102 DATE AS OF CHANGE: 20161102 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ANTARES PHARMA, INC. CENTRAL INDEX KEY: 0001016169 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 411350192 STATE OF INCORPORATION: DE FISCAL YEAR END: 1208 BUSINESS ADDRESS: STREET 1: 100 PRINCETON SOUTH STREET 2: SUITE 300 CITY: EWING STATE: NJ ZIP: 08628 BUSINESS PHONE: 609-359-3020 MAIL ADDRESS: STREET 1: 100 PRINCETON SOUTH STREET 2: SUITE 300 CITY: EWING STATE: NJ ZIP: 08628 FORMER COMPANY: FORMER CONFORMED NAME: ANTARES PHARMA INC DATE OF NAME CHANGE: 20060120 FORMER COMPANY: FORMER CONFORMED NAME: ANTARES PHARMA INC DATE OF NAME CHANGE: 20020520 FORMER COMPANY: FORMER CONFORMED NAME: ANTARES PHARMA INC /MN/ DATE OF NAME CHANGE: 20010604 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Powell Fred M CENTRAL INDEX KEY: 0001331339 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-32302 FILM NUMBER: 161968869 MAIL ADDRESS: STREET 1: C/O BEJING MED-PHARM CORPORATION STREET 2: 600 W. GERMANTOWN PIKE, SUITE 400 CITY: PLYMOUTH MEETING STATE: PA ZIP: 19462 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2016-10-31 0 0001016169 ANTARES PHARMA, INC. ATRS 0001331339 Powell Fred M C/O ANTARES PHARMA, INC. 100 PRINCETON STREET SOUTH, SUITE 300 EWING NJ 08628 0 1 0 0 Senior Vice President & CFO Stock Option (right to buy) 1.76 2016-10-31 4 A 0 150000 0.00 A 2026-10-31 Common Stock 150000 150000 D Represents grant of options to purchase shares of common stock, par value $0.01 per share, issued under the Antares Pharma, Inc. 2008 Equity Compensation Plan. The options vest in equal quarterly installments over three years from the date of grant. /s/ Peter J. Graham as attorney-in-fact for Fred M. Powell 2016-11-02 EX-24.4_681937 2 poa.txt POA DOCUMENT LIMITED POWER OF ATTORNEY FOR SECTION 16 REPORTING OBLIGATIONS KNOW ALL PERSONS BY THESE PRESENTS, that I, Fred M. Powell, hereby constitute and appoint Robert F. Apple, Peter J. Graham and Keith Muckenhirn, each of them, my true and lawful attorneys-in-fact and agents, each acting alone, with full powers of substitution and resubstitution for me and in my name, place and stead, to sign any reports on Form 3 (Initial Statement of Beneficial Ownership), Form 4 (Statement of Changes in Beneficial Ownership of Securities) and Form 5 (Annual Statement of Changes in Beneficial Ownership) relating to transactions by me in Common Stock or other securities of Antares Pharma, Inc., and all amendments thereto, and to file the same with the Securities and Exchange Commission and appropriate securities listing agency, if required, granting unto said attorneys-in-fact and agents, and each of them, or their substitutes, full power and authority to do and perform each and every act and thing requisite or necessary to be done, as fully to all intents and purposes as I might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents, and each of them, or their substitutes, may lawfully do or cause to be done by virtue hereof. This Power of Attorney shall be effective until such time as I deliver a written revocation thereof to my above-named attorneys-in-fact and agents. Signed: /s/Fred M. Powell Dated: October 31, 2016